1,4-dideoxy-1,4-iminoarabinitol has been researched along with miglustat in 2 studies
Studies (1,4-dideoxy-1,4-iminoarabinitol) | Trials (1,4-dideoxy-1,4-iminoarabinitol) | Recent Studies (post-2010) (1,4-dideoxy-1,4-iminoarabinitol) | Studies (miglustat) | Trials (miglustat) | Recent Studies (post-2010) (miglustat) |
---|---|---|---|---|---|
58 | 0 | 25 | 383 | 28 | 185 |
Protein | Taxonomy | 1,4-dideoxy-1,4-iminoarabinitol (IC50) | miglustat (IC50) |
---|---|---|---|
Sucrase-isomaltase | Mus musculus (house mouse) | 1.05 | |
Maltase-glucoamylase, intestinal | Homo sapiens (human) | 5.55 | |
Lysosomal acid glucosylceramidase | Homo sapiens (human) | 5 | |
Lysosomal alpha-glucosidase | Homo sapiens (human) | 0.1 | |
Sucrase-isomaltase, intestinal | Homo sapiens (human) | 0.5 | |
Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | 2.156 | |
Protein-lysine 6-oxidase | Homo sapiens (human) | 5 | |
Glycogen debranching enzyme | Homo sapiens (human) | 10 | |
Lysosomal alpha-glucosidase | Mus musculus (house mouse) | 9 | |
Non-lysosomal glucosylceramidase | Mus musculus (house mouse) | 0.14 | |
Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | 3.7 | |
Non-lysosomal glucosylceramidase | Homo sapiens (human) | 0.2057 | |
Putative alpha-glucosidase | Oryza sativa Japonica Group (Japanese rice) | 0.42 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, I; Hayashi, E; Hirono, S; Imahori, T; Kato, A; Koseki, J; Miyauchi, S; Nakagome, I; Nash, RJ; Natori, Y; Shimaoka, H; Takahata, H; Yoshimura, Y | 1 |
Fleet, GWJ; Jia, YM; Kanekiyo, U; Kato, A; Kishida, M; Li, YX; Lu, TT; Nakagome, I; Nash, RJ; Shinzawa, K; Tanaka, N; Yoshida, T; Yoshimura, K; Yu, CY | 1 |
2 other study(ies) available for 1,4-dideoxy-1,4-iminoarabinitol and miglustat
Article | Year |
---|---|
α-1-C-butyl-1,4-dideoxy-1,4-imino-l-arabinitol as a second-generation iminosugar-based oral α-glucosidase inhibitor for improving postprandial hyperglycemia.
Topics: Administration, Oral; Animals; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Imino Sugars; Inhibitory Concentration 50; Male; Mice; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
5-
Topics: 1-Deoxynojirimycin; Alkylation; alpha-Glucosidases; Enzyme Inhibitors; Fibroblasts; Glycogen Storage Disease Type II; Humans; Molecular Dynamics Simulation; Molecular Structure; Mutation; Protein Conformation; Protein Stability; Recombinant Proteins | 2022 |